- Home
- VANI vs FNWB Comparison
VANI vs FNWB Comparison
Compare VANI & FNWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VANI
- FNWB
- Stock Information
- Founded
- VANI 1998
- FNWB 1923
- Country
- VANI United States
- FNWB United States
- Employees
- VANI N/A
- FNWB N/A
- Industry
- VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- FNWB Banks
- Sector
- VANI Health Care
- FNWB Finance
- Exchange
- VANI Nasdaq
- FNWB Nasdaq
- Market Cap
- VANI 81.2M
- FNWB 69.1M
- IPO Year
- VANI 2014
- FNWB 2015
- Fundamental
- Price
- VANI $1.61
- FNWB $9.07
- Analyst Decision
- VANI Strong Buy
- FNWB Hold
- Analyst Count
- VANI 1
- FNWB 1
- Target Price
- VANI $4.00
- FNWB $12.00
- AVG Volume (30 Days)
- VANI 484.1K
- FNWB 12.5K
- Earning Date
- VANI 11-13-2025
- FNWB 10-27-2025
- Dividend Yield
- VANI N/A
- FNWB 2.25%
- EPS Growth
- VANI N/A
- FNWB N/A
- EPS
- VANI N/A
- FNWB N/A
- Revenue
- VANI N/A
- FNWB $59,854,000.00
- Revenue This Year
- VANI N/A
- FNWB $34.16
- Revenue Next Year
- VANI N/A
- FNWB $11.73
- P/E Ratio
- VANI N/A
- FNWB N/A
- Revenue Growth
- VANI N/A
- FNWB 17.90
- 52 Week Low
- VANI $0.91
- FNWB $6.05
- 52 Week High
- VANI $1.92
- FNWB $12.10
- Technical
- Relative Strength Index (RSI)
- VANI 53.84
- FNWB 69.22
- Support Level
- VANI $1.59
- FNWB $8.91
- Resistance Level
- VANI $1.81
- FNWB $9.50
- Average True Range (ATR)
- VANI 0.15
- FNWB 0.24
- MACD
- VANI 0.00
- FNWB 0.14
- Stochastic Oscillator
- VANI 49.18
- FNWB 75.29
About VANI Vivani Medical Inc. (DE)
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.